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Summary.-Using a direct radioimmune antiglobulin technique and a competitive
double-antibody radioimmune assay, we have demonstrated the presence of appreci-
able amounts of host immunoglobulins on the surface and in extracts of cell suspen-
sions from freshly excised solid tumours. IgA appeared to have the greatest concen-
tration, followed in turn by IgM-IgG2a > IgGl-IgG2b > IgG3. The amount of
immunoglobulin appeared to be influenced by the tumour under investigation and
its mode of maintenance. It could also be increased by the administration of
C. parvum but was not significantly influenced by the T-cell status of the host.
WHILE in the literature there are many
reports on circulating antitumour anti-
body responses to tumours (e.g. Ting &
Herberman, 1976) there have been few
attempts to quantitate the immuno-
globulin content, antibody or otherwise,
of solid tumours in vivo. Recently WVitz
(1977) has advanced the case for more
detailed studies on tumour-bound im-
munoglobulins arguing that in many
situations such an association is an in situ
expression of humoral immunity to
tumours. If this were the case, studies
on tumour-associated immunoglobulins
should provide information of both
theoretical and therapeutic importance.
Furthermore, such studies are a logical
sequel to those recently pursued on the
host lymphoreticular cell content of solid
tumours in vivo.
Prompted by Witz's remarks and his
observations in ascites tumour models
(Witz, 1977) we decided to develop sensi-
tive techniques to investigate the asso-
ciation of immunoglobulin with freshly
excised solid tumours. In the present
paper we report our results with a direct
antiglobulin technique which detects sur-
face-associated immunoglobulin, and a
competitive double-antibody radioim-
munoassay technique which permits the
quantitation ofindividualimmunoglobulin
classes or subclasses in tumour-cell ex-
tracts. These techniques have been used
to compare the response to two different
transplanted tumours and to ascertain the
effect on the response to one of them of
Corynebacterium parvum and the influence
of the T-cell status of the host. Whilst the
specificity of this association still remains
to be established, a number of interesting
points emerge from these initial studies.
MATERIALS AND METHODS
Mice.-All the investigations were per-
formed in inbred CBA/Ca male mice age
10-12 weeks. These mice were bred from stock
initially obtained from the MRC Laboratory
Animals Centre, Carshalton, Surrey.
T-cell deprived mice were prepared by
thymectomizing 5-week-old mice and subject-
ingthem one week later to 800 rad -whole-body
irradiation w-ith thorax shielding. Sham
thymectomized, irradiated, control mice
were also prepared. The mice were used 9
weeks after irradiation. The immune status of
the intact, sham-thymectomized and thymec-
tomized group was always assessed by
challenging (i.p.) about 8 mice in each group
with 3 x 108 sheep erythrocytes and measur-
ing 10 days later the levels of circulating
antibody (mercapto ethanol sensitive and
resistant) by standard passive haemaggluti-K. JAMES, Y. H. I BESSOS AND J. MERRIMAN
nation techniques. The mice were also
routinely checked at the time of killing for
thymic remnants. It should also be stressed
that the T-cell deprived mice and appropriate
control groups were housed throughout the
experiment in a laminar-flow tissue-culture
cabinet and fed expanded pasteurized diet
and acidified water.
Tumours. Two transplanted syngeneic
tumours were used in this study, namely a
methylcholanthrene-induced fibrosarcoma
(CCH1) and a fibrosarcoma (T3) originally
obtained by the injection of mice with
embryonic cells which had undergone spon-
taneous transformation in vitro. The CCH1
tumour, which was in its 21-27th transplant
generation, was at least 10 times as immuno-
genic as the T3 tumour, which was in its 2nd
transplant generation following culture
(James et al., 1979).
Except where otherwvise stated, freshly
excised tumour-cell suspensions were used
for challenge. These were obtained by pronase
digestion (Woodruff & Boak, 1966). Cultured
tumour cells when used were maintained and
harvested as previously described (Ghaffar
et al., 1974).
Reagents. The rabbit anti-mouse IgG
used in the direct antiglobulin assay was
purchased from Dako-immunoglobulins,
Copenhagen, Denmark. Gel-diffusion pre-
cipitin analyses revealed that this reagent,
which was in the form of a globulin fraction,
reacted with all the major immunoglobulin
classes and subclasses. Prior to use in the
antiglobulin assay it was absorbed exten-
sivelv with cultured CCH1 and T3 tumour
cells and labelled with 1251 by the chloramine
T procedure of Hunter & Greenwood (1962).
After labelling the antibody was diluted in
phosphate-buffered saline containing 100
(w/v) of 3 x crystallized bovine serum
albumin (Armour Pharmaceuticals, Chicago,
U.S.A.) and centrifuged at 76,000 g for 1 h
and finally stored in aliquots at -20°C.
The rabbit antisera to mouse classes and
subclasses, and the purified proteins them-
selves, were obtained from Litton Bionetics
Incorporated, Kensington, Maryland, U.S.A.
These antisera had been rendered mono-
specific by solid-phase absorption, and their
specificity was confirmed by competitive
radioimmunoassay (Figs la and b). The
purified Ig immunoglobulins were also
labelled when necessary by the Hunter &
Greenwood technique (1962). Th-e donkey
antirabbit-IgG serum used as the second
reagent in the competitive radioimmunoassay
was purchased from Wellcome Reagents Ltd,
Beckenham, Kent.
Assay procedures. Tumours Nere excised
from individual mice at various times after
transplantation and tumour-cell suspensions
generally prepared by gently disrupting with
scalpel blades in RPMI medium containing
10% (w/v) FCS. In more recent experiments
however the tumour-cell suspensions have
been obtained by digestion of small tumour
segments (1-2 mm) with a highly purified
collagenase solution (Grade A collagenase
supplied by Calbiochem, San Diego, Cali-
fornia, U.S.A.). This digestion was performed
for 30 min at 37°C with a 01 mg/ml col-
lagenase solution in Dulbecco A. The
viability of individual tumour-cell suspen-
sions was routinely assessed by the trypan-
blue dye-exclusion technique, and ranged
from 10-500o in the case of mechanically
prepared suspensions to 7500/ or more after
collagenase treatment. It should be stressed
that the tumour-cell preparations were in the
form of single-cell suspensions, and that
additional studies indicated that the amount
of immunoglobulin associated with tumour-
cell suspensions bore no relation to their
viability. The tumour-cell suspensions thus
obtained were washed x 4 in medium and
then submitted to the following assays.
The presence of immunoglobulin on the
surface ofthe tumour cells was determined by
a direct radioimmune antiglobulin technique.
The tumour cells under test (5 x 104 in 100 pu
of the above RPMI/FCS medium) were dis-
pensed in quadruplicate into polystyrene
tubes which had been precoated overnight
with 5% (v/v) foetal calf serum in PBS. The
cells were then incubated for 1 h at 4°C with
4 ,tg of 1251-labelled antimouse immuno-
globulin (see above). After incubation the
tumour cells were extensively washed x 4 in
4 ml of PBS containing 500 (v/v) FCS prior
to counting in a Wallac gamma scintillo-
meter. Control tubes containing cultured
tumour cells or medium alone were routinely
included in each assay. The amount of anti-
globulin bound was determined by reference
to the TCA-precipitable counts in the original
labelled preparation of known immuno-
globulin concentration. The results presented
in the figures and tables are the amount (ng)
immunoglobulin bound to the tumour cells
under test, less the amount bound to tube.s
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Fia. 1. Demonstration of the specificity of
the antisera used in the competitive radio-
immunoassay and Mancini procedures. The
ability of various purified Igs to inhibit the
binding of labelled IgA (a) and IgGI (b) by
their respective antisera is compared. Note
that whilst unlabelled IgA and IgGI
readily inhibit binding, the other proteins
are relatively ineffective. A similar degree
ofspecificity was also seen with all the other
antisera.
containing cultured tumour cells or medium
alone. The latter two values, which reflect
non-specific binding of the labelled anti-
globulin reagent, were usually similar but did
vary from test to test.
The total amount of each immunoglobulin
associated with the tumour-cell surface and
cytoplasm was determined by competitive
47
radioimmunoassay on tumour-cell extracts.
The latter was prepared by extracting 2 x 107
tumour cells for 30 min at room temperature
with 1 ml of 1% (w/v) Nonidet P40 (British
Drug Houses, Poole). After extraction the
samples were clarified by centrifugation in a
bench centrifuge and 200 u/ml of Trasylol
(Calbiochem) added to inhibit proteolytic
degradation. The samples were then diluted
with an equal volume of radioimmunoassay
buffer (Wide et al., 1973) and dispensed into
aliquots and stored at -20°C prior to assay.
The assay itself was performed on quadru-
plicate samples as follows. To lOOjul aliquots
of the extracts and the appropriate immuno-
globulin standards in polycarbonate tubes,
was added 10 jul of a predetermined concen-
tration ofprimary antibody in diluted normal
rabbit serum carrier. This mixture was then
incubated for 3 h at 37°C followed by over-
night incuibation at 4°C. The second stage in-
volved incubating the tube contents as above
with 10 ,ul (200-500 pg) of the appropriate
labelled purified antigen. This had been
labelled at 4-10 pCii4ttg protein. The final pre-
cipitation step involved the addition of 100 ,ul
of donkey antirabbit immunoglobulin (dil
x 40) followed by incubation either of 3 h at
37°C or overnight at 4°C. After the final
incubation 4 ml of washing buffer (PBS con-
taining 0.5% (v/v) Tween and 0.5% (v/v)
soluble starch) was added to each tube and
the precipitates recovered by centrifugation
at 1500 g for 30 min. The supernatant was
removed by decanting and blotting. The pre-
cipitates thus obtained were counted in a
Wallac gamma scintillometer and the im-
munoglobulin content of the unknown
samples was determined by reference to a
standard inhibition curve.
The immunoglobulin class and subclass
content of individual mouse sera was esti-
mated by the single-radial immunodiffusion
method of Mancini et al. (1965). Duplicate
assays were undertaken on each serum, and
all plates contained a range of dilutions of
purified immunoglobulin standards or of a
standard serum.
Presentation ofresults.-Except where indi-
cated (see Table IV) the results have been
expressed as arithmetic means together with
the sta,ndard deviation of the mean or the
standard errors (see Figs). The significance of
the results has been assessed by the t-test,
whilst the correlation coefficients were deter-
mined by linear-regression analysis.
691
90K. JAMES, Y. H. I. BESSOS AND J. MERRIMAN
;.
1-1 *_t (Z
¢ ~
* *
* *
w cq N 0
+l +1 +1 +1 3%0 E 0 Co 0
_ *
D < O -4 O O4
,°+l +1 +1 +1
-4--40
- -4
c0 -4
c 1+ 1+10+IN +I
COO -
0 to C0 0 iOo
C +1+1+1+1 +V+IV+I
O m _4 la
C0C-0O 0 C0_ > +1 +1 +1 +1 +1 + +1 +
q 00to _ms ,. to :
0 = Ob =
OC> O- C> OC) 0 00
' +1 +1 +1+ +1+1+1 +1
e "dim =CON4 * 4 Nq c*z CObt
¢ +l1+1+l+l +l1+1+1+l
m X 4X£C
C C) C)
(D t ;;;~ ;~
e e 0 E 0 A-242FrJO 4
U1 00 _-- _-
E--
i0
IC$
a)
692
Ies
cv
ct
Z:
*
CO
H.
0
0
11m 4-Q "
)() 0 e ;=
. > 11 a)4
.;o
1) (1)
4 V. -4 ') . 4-
:5 C', . o
z
w r.
z 0
:) -1-4
4-)
.4 (L)
a) :1 -+5
..) (1)
1) 'cl
. C4,
S oHOST IMMUNOGLOBULINS IN SOLID TUMOURS
RESULTS
A comparison of the response to CCH1 and
T3 tumour injected into different animals
In these experiments groups of mice
were challenged s.c. with either 106 viable
CCH1 or T3 tumour cells obtained
by pronase digestion of freshly excised
tumours. At various intervals there-
after tumours were removed and the
amount ofimmunoglobulin associatedwith
a standard number of tumour cells was
assessed by both the direct antiglobulin
procedure and the competitive radio-
immunoassay technique. The results of
these studies are summarized in Figs 2
and 3 and Table I.
The direct antiglobulin technique re-
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vealed that an appreciable amount of
immunoglobulin was associated with the
surface of freshly excised CCHI and T3
tumours (Fig. 2). The amount appeared to
increase with tumour age and to exhibit a
direct correlation withtumoursize (Fig. 3).
On all but one occasion, the amount of
immunoglobulin associated with the sur-
face ofthe CCH1 tumour was significantly
greater than that observed on the less
immunogenic, and more rapidly growing,
T3 tumour.
The competitive radioimmunoassay
procedure confirmed that appreciable
amounts of immunoglobulin were asso-
ciated with solid tumours in vivo (Table I).
Once more there were differences in the
amounts of immunoglobulin associated
1 5 20 25 30
30
25 4
I-.
H
15 4 1n
DAY
FIG. 2.-Amount of Ig bound to cell surfaces of different syngeneic tumours. CBA mice were injected
s.c. on Day 0 with 106 viable freshly excised CCH1 or T3 tumour cells. At various times thereafter
the amount of host Ig associated with the surface of 5 x 104 cells from individual tumours was
indirectly assessed by an antiglobulin procedure. Note that the amount ofimmunoglobulin present
on the T3 tumour is significantly less (*) than that on CCH1 tumours. In addition the T3 tumour
exhibits a significantly faster growth rate (**). Bars indicate s.e.
693
CCH1
35.7
IlI Il IVK. JAMES, Y. H. I. BESSOS AND J. MERRIMAN
14
12
10
c
0
0 8
m
Is
D 6
< 4
2
0
0
r =0.75
* 0
0
0
10 15 20 25 30 35
TUMOUR DIAMETER (mm)
FiG. 3. Relationship between the amount of
Igbound to a tumour and its diameter. The
antiglobulin values determined in the ex-
periment illustrated in Fig. 2 have been
plotted against tumour diameter for CCH1
(*) and T3 (0). Note that there is a direct
correlation between these values.
with CCH1 and T3 tumours, significantly
more being present in the CCH1 extracts.
There were also marked differences in the
relative concentrations of the various
immunoglobulins, which ranked in the
following order: IgA>IgM 1gG2a>
IgG1lIgG2b > JgG3. These concentra-
tions bore no relation to those in serum of
the tumour-bearing animals, where IgG2a
>IgGI>IgA-IgG2bIgM> IgG3 (see
Table I). The serum Ig levels were similar
to those previously found in normal mice.
However, it should be stressed that in
mice bearing older tumours there is
usually a significant decrease in the levels
of all immunoglobulin classes and sub-
classes (James et al., 1977).
Further investigations with the CCH1
tumour revealed that the observations on
the immunoglobulin content of tumour
extracts were highly reproducible (Table
II). These data also suggest that the im-
munoglobulin content of tumour extracts
may decrease with age. This contrasts
with our observations on cell-surface
immunoglobulin (see above). It should also
be noted that on no occasion have we been
able to detect any immunoglobulin in
extracts of cultured CCH1 or T3 tumour
cells.
A comparison of the response to tumours
injected into the opposite limbs of the same
animal
In these experiments the response to
tumours injected into the opposite limbs
of the same animal were compared. When
freshly excised CCH1 tumour was injected
into both limbs the amount of immuno-
globulin in both tumours was similar
(Fig. 4). However, differences in the
TABLE II.-Comparison of tumour-associated Ig levels in a series of experiments with
CCH1 tumour
Exp. Day
No. examined
1 23
30
2 16
18
3 15
4 ?
5 15
18
6 17
26
7 15
No. of r-
tumours M
5 101+_:
5 44+(
10 12-8+ (
3 118_+
5 Not tee
4 8-5+
5 9 5+(
5 6-4+
5 5-7+(
5 6-3+(
5 Not tes
Ig extracted from 107 cells (ng)
A GI G2a G2b
1-2
0-4
0.9
4-4
sted
1-1
0[7
0-8
0-7
0-6
26-3+8-8
18-0+ 5-8
29-1+5-7
26-0+ 15-4
31-7 + 14-5
37-3+7-1
44-2+2-2
16-5+ 3-3
21-6 + 4-6
16-3+ 6-9
;ted 102-3+ 38-9
6-3 + 0-9
4-9+0-9
4-3 + 0-8
5-5+0-9
2-3+0-6
2-9+0-1
2-6+0-1
2 4 +02
2-5+0-3
2-1+0-2
3-7+0-3
16-2+2-0 6-6+0-8
15-8 + 1-0 7-6 + 1-7
12-6 + 2-0 6-8 + 1-0
13-8+2-0 5-8+0-8
12-4+1-1 <1
10-8+0-7 6-1+0-9
105+0-8 <1
10-0+0-9 <1
9-1+0-9 <1
10-7+ 1-1 < 1
Not tested Not tested
Note that the major Ig in tumour extracts is IgA followed in turn by IgG2a-IgM> IgGI =
IgG2b > IgG3.
G3
Not tested
Not tested
<3
<3
Not tested
Not tested
<3
<3
<3
<3
<3
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FIG. 4. Comparison of the amount of Ig
bound to tumours obtained from contra-
lateral sites. In these experiments mice were
challenged in contralateral sites with 106
viable tumour cells of the type indicated.
The cell surface Ig levels (per 5 x 104 cells)
were determined 16 days later by the anti-
globulin technique. Note that even within
the same animal, freshly excised CCH1
tumour (0) evokes a greater response than
cultured CCH1 tumour (0) or freshly
excised T3 tumour (A).
response to CCH1 and T3 were noted, thus
confirming the pattern observed when
these tumours were injected into different
animals (Fig. 2). Of additional interest
was the observation that significantly less
immunoglobulin was associated with
tumours grown from cultured CCH1 cells.
It should be noted that results similar to
those shown in Fig. 4 have been observed
on a number of occasions.
The influence of C. parvum on tumour-
associated immunoglobulin levels
Previous studies from our laboratory
have shown that administration of C.
parvum by the i.p. route significantly in-
creases the levels of certain serum im-
munoglobulins and causes the develop-
ment of antibodies which bind to tumour
cells in vitro (e.g. James et al., 1976).
Experiments were therefore performed to
ascertain whether C. parvum treatment
might influence the amount of immuno-
globulin associated with solid tumours in
vivo. In these experiments mice were
challenged with 106 freshly excised CCH1
cells on Day 0, and injected i.p. 3 days
later with 1-4 mg of C. parvum, and the
association of immunoglobulin with the
resulting tumours was assessed as above.
It will be seen in Fig. 5 that C. parvum
administered to tumour-bearing animals
may significantly increase the concentra-
tion ofcell-surface immunoglobulin, whilst
simultaneously inhibiting tumour growth.
In addition it also increases the concen-
tration of certain immunoglobulins in
tumour extracts (Table III). This effect
was most consistently noticed with respect
to IgA though significant increases in
IgM and IgGI were also sometimes seen.
Influence of the T-cell status of the host on
tumour-associated immunoglobulin levels
In these experiments mice were T-cell
deprived and sham treated as described in
the Materials and Methods section. As
usual, some ofthe mice in each group were
challenged s.c. with 106 freshly excised
CCH1 tumour cells. The others were
challenged (i.p.) with 3 x 108 sheep
erythrocytes. At intervals thereafter
tumours were removed from the mice for
tumour-immunoglobulin assays, or the
mice bled and antibodies to sheep erythro-
cytes assayed by passive haemagglutina-
tion.
These studies revealed that whilst
T-cell-deficient mice failed to respond
normally to sheep erythrocytes, the
amount of immunoglobulin associated
with tumours grown therein was not sig-
nificantly different from that seen in
tumours grown in intact or sham-treated
mice (Table IV). Thus the binding of
immunoglobulins to solid tumours in situ
appears to be a T-cell-independent pro-
cess.
DISCUSSION
The present results confirm and extend
our preliminary observations that appreci-
able amounts of most immunoglobulin
classes and subclasses are associated in
vivo with certain transplanted experi-
695S
R L
4
2
0
-18
6K. JAMES, Y. H. I. BESSOS AND J. MERRIMAN
IC IC It
'I vi:
'I
02 02 02 02
0 02 ri r mt m 60 ce
0 0 0 0 0 0
40; .4;040
o o
CON00
co 0 -0 021 " c
oo r) CD O
+1+1+1 +1
00 5 w
+1 +1+1 +1 +1
10 -
cq r w cs 7 +I +I +I +I +I
GQ00 10 r-- 00e
o41 +1 +1 +1+1 +1
* *
¢ +l1+1+1+l +l
e o b
6. . * .
e o>
F
0
14
.0
oC 1-4
CS
*4 CC
02
6
CO In
4L
IV
6
P4 c1+2
x lo, d 0lo U CO
0
0p4 m o
es
10
~40
.0
94--+>2
H~;~ 4~
00 w b
* >
C 10n e
C) oo;
-1+1+1 +
N1 001 "
"CC) -1 +1+1*+1 *- 0
D q100C 0
-- -I+l +l +l
O04
Ca _ s
-I +l +l +I -
o 4 ' 110S: C'O _
-0
OC
4
r O° 4)
O
FF2OC
oo
-
d 10A . 1-
A +
¢I _;C}o
C.)
C.)
*gSt
Ile
C.)
CO
E-q
I.
H-Z
02
m
5-4
(14
v H0
0
*
01:
+1
*
+1
CO
+1
N?
*
oo 10 1o
6 6
+l +1 +1
t C CO r
. .
r cs en
+l +1 +1
02 0 CO
+l +I +1
10010 x
C666
1-
.
-I
CO m mm MM
V V V 0 vv vv V V V
* ^ _q _fr- m m
V V VV 40 40 40
0 40 40
01 ~
m 60 66
5 +1 +1 +1 +1
c,
CO0 CXOO
+1 +1 +1 +1
C O<
.q r-
¢ +1+l +1+l
COCn
NCO
66 66
+1 +1 +1 +1
r "
,b ix
0d +-
._
40) 40-
M m
0
40
-40 40
0 0
~
0)
40)
40
0
+1 +1 +1
10
+1 +1 +l
10
O CO
-II P-
40 4
40 0 40
40 0 40
zzz
CO NC 10
41 C- r--l
0
14
1)~
.Q
696
to 02
00
C)
r-
v
V-4
0
40'.
C)
bD
H-
CO
C.)
C.)
C.L)
Ct
I'd
c3
tv
I
EQ
0
0
0
4_,
C)
0 6q
0
C)S
>, Q
o 0
CD
d 0
V
* 0
0
0H X
. D~
0 ,
20
f 0 _
-W 02
; 0 d
O ;
o 02
fv
o0
II;,HOST IMMUNOGLOBULINS IN SOLID TUMOURS
mental tumours in mice (James et al.,
1978a). Without exception, IgA was
present in greatest concentrations in
tumour extracts, whilst the minor com-
ponents were usually IgGl, IgG2b and
IgG3. A number of factors appeared to
influence this association. For example,
greater amounts appeared to be associated
with the moreimmunogenic CCH1 tumour.
Furthermore, preliminary studies suggest
that in the early stages of tumour growth
there was more immunoglobulin on the
surface of tumours grown from freshly
excised tumour cells than on those grown
from cells which had been maintained in
culture. Finally, the amounts of immuno-
globulin present could be increased by
administeringadjuvantssuch asC. parvum,
but were largely unaffected by the T-cell
status of the tumour-bearing host.
At the present time we have no direct
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information on the specificity of the
observed response. As previously sug-
gested by Witz (1977) the association
could be accounted for in a number of
ways, including (a) the specific interaction
of antitumour antibodies with tumour
antigens, (b) the binding of certain im-
munoglobulins to Fc receptors on infiltrat-
ing host cells such as macrophages or B
cells, (c) the presence of host B cells bear-
ing surface immunoglobulin or, (d) the
local production of immunoglobulin by
infiltrating plasma cells. A number of
observations lead us to believe that the
effect is not due to the non-specific binding
of immunoglobulin to Fc receptors on
infiltrating host cells. In the first place
such an association would be expected to
show class and subclass restriction. Under
such circumstances it would be difficult to
envisage why our tumours contain so
15 18 21
H
0
FIG. 5.-Influence of C. parvum on the amount of Ig bound to tumour-cell surfaces. All mice were
injected s.c. on Day 0 with 106 viable CCH1 tumour cells, and 3 days later half of the mice (right
hand figure) were injected i.p. with 1-4 mg of C. parvum. Note that the administration of C. parvum
significantly increases the amount of Ig detected on tumour-cell surfaces (*) whilst significantly
inhibiting tumour growth (**).
-C. parvumn
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much IgA, for this protein does not bind
to Fe receptors on B cells or macrophages.
However, it is conceivable that this pro-
tein might be associated with infiltrating
neutrophils, for it has recently been sug-
gested that such cells may possess recep-
tors for the Fc region of IgA (van Epps
et at., 1978). Furthermore, the tumour-cell
suspensions were rigorously washed before
assay, a procedure which is generally
believed to remove immunoglobulin which
may be loosely bound via Fc receptors. It
should be stressed that other observations
from our own laboratory lead us to
believe that the responses observed are
not against antigens expressed on, or in-
duced by, endogenous murine leukaemia
virus (James et al., 1978a, b). The differ-
ence noted in the response to freshly
excised and cultured tumour-cell suspen-
sions have been noted in several other
systems, and possible explanations of this
have previously been advanced by our
laboratory (James et al., 1979). At
present, we feel that the differences are
probably due to the modulation of the
host response by sensitized lympho-
reticular cells present in tumour-cell sus-
pensions from freshly excised tumours,
rather than to inherent differences in the
antigenicity of the two preparations.
Furthermore, this modulating effect may
be one of suppression or enhancement,
depending on the immune parameter
studied.
The significance of the responses noted
also remains to be established and certain
paradoxical effects explained. It is recog-
nized, at least from in vitro studies, that
antitumour antibodies may exert a
variety of effects which may be of benefit
to either the host or the tumour. However,
it is perhaps not generally appreciated
that small amounts of antibody, not
sufficient in themselves to destroy solid
tumourbycomplement-dependent or other
means, might initiate certain events
which could be important to the host. For
example, the binding of small amounts of
complement-fixing antibody to tumour-
specific or tumour associated antigens
could conceivably activate the direct
complement pathway, with the generation
of a variety of complement components
which might increase vascular perme-
ability, and the infiltration and subse-
quent localization of host cells. Such com-
ponents include C3b, C4b, kinins and
anaphylotoxins.
As previously remarked, some of our
observations appear paradoxical. Whilst
the results in Fig. 3 indicate that the
amount of immunoglobulin associated
with tumour-cell surfaces is directly re-
lated to size, other observations suggest
an inverse relationship. Thus more im-
munoglobulin is detected on the surface
of CCH1 tumour cells than on the surface
of the faster growing T3 tumour (Fig. 2).
Furthermore C. parvum protocols which
inhibit growth increase the levels of
immunoglobulin on tumour-cell surfaces
(Fig. 4). It is believed that this paradox
might be explained on the basis of differ-
ences in the amounts of the various im-
munoglobulin classes and subclasses asso-
ciated with tumour membranes in this
situation, and further experiments are
under way to test this possibility.
The observation that IgA was the major
immunoglobulin in tumour extracts was
completely unexpected, and is in contrast
to observations in other experimental
tumour models (e.g. Haskill et al., 1977;
Maov & Witz, 1978). It is of interest
however in relation to a number of recent
observations. In the first place, plasma
cells of the IgA type have been seen to
accumulate in the connective tissues sur-
rounding nests of nasopharyngeal car-
cinoma cells (Ho et al., 1978). Whether or
not a local IgA response is preferentially
evoked in our tumour models remains to
be established, but this possibility is of
obvious theoretical importance. It is also
now apparent that polymeric IgA may
interact with neutrophils via their Fc
region and as a result suppress their
chemotactic and bactericidal activity
(van Epps & Williams, 1976; van Epps
et al., 1978; Milton, 1978). Should the
observed association of IgA with tumours
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involve interaction with tumour-specific
or tumour-associated antigens, with the
subsequent formation of soluble immune
complexes, this could affect the neutrophil
function of the tumour-bearing host.
Whereas in our studies we have been
able to demonstrate the association of
large amounts of IgA with tumour-cell
extracts, we have no information at pre-
sent on whether the IgA is present on the
cell surface or localized within the cyto-
plasm. In this connection it is interesting
to note that using similar techniques to
our own, others have noted the presence
of large amounts of IgA in rat thymocyte
and thoracic-duct lymphocyte extracts,
this being almost exclusively located in
the cytoplasm (Jensenius & Williams,
1974).
The ability of C. parvum to increase the
amount of immunoglobulin associated
with tumour is of interest though its
relevance, ifany, to the antitumour effects
of this agent still remains to be estab-
lished. The assays on cell extracts indicate
that the effects may be class or subclass
restricted. Thus, whilst C. parvum therapy
consistently caused a significant increase
in the levels of tumour IgA and IgM, it
rarely elicited a significant increase in
IgG2a and IgG2b. These effects contrast
with those observed with respect to serum
immunoglobulin levels were the same
C. parvumn protocol increases the level of
all classes and subclasses, but especially
IgG2a and IgG2b (James et al., 1976;
1977). Whilst these differences suggest
selective binding or local production of
certain immunoglobulins by infiltrating
host cells, these possibilities have still to
be investigated.
The present studies clearly demonstrate
that appreciable amounts of immuno-
globulin are associated with certain solid
tumours in vivo. Whether this association
represents an in situ expression of a
humoral immune response to tumour
antigen, and is ofany relevance to tumour
growth, remains to be established. Further
insight into this matter will undoubtedly
accrue from experiments currently under
way in our laboratory which are designed
to ascertain whether immunoglobulin
eluted from the surface of tumours ex-
hibits specific binding and to establish
whether or not spontaneous tumours
elicit similar in situ responses.
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